Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{185689,
        author = {Deeksha D Ghatge and Dhanshree Lakudkar and Md Quamruz Zafar},
        title = {Nutraceutical Interventions for Women’s Health: A Clinical Evidence Landscape},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {5},
        pages = {2483-2499},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=185689},
        abstract = {Women’s health encompasses multiple life stages- adolescence, reproductive years, pregnancy, menopause and aging, each characterized by distinct physiological and nutritional demands. Meeting these needs often requires interventions that go beyond conventional therapies, where nutraceuticals have gained increasing attention as natural, accessible and preventive strategies. Nutraceuticals such as phytoestrogens, isoflavones, omega-3 fatty acids, vitamins, minerals, probiotics and plant-derived bioactives offer diverse health benefits by acting through multiple biological pathways. Unlike single-target pharmacological approaches, these compounds contribute to hormonal balance, preservation of bone mineral density, cardiometabolic regulation, cognitive support, immune modulation and maintenance of urogenital health.
This clinical study map integrates evidence on nutraceutical applications across key domains of women’s health, including reproductive and maternal health, menstrual disorders, menopausal transitions, skeletal health, cardiovascular and metabolic conditions, mental well-being and urogenital balance. The analysis underscores their potential to improve quality of life, alleviate symptoms and support preventive care. However, the review also identifies major gaps, including heterogenous study designs, limited sample sizes, underrepresentation of diverse populations and lack of standardized formulations and dosing protocols. Addressing these limitations requires rigorous, large-scale and personalized research approaches, alongside clearer global regulatory frameworks, to ensure the safety, efficacy and integration of nutraceuticals into evidence-based women’s healthcare.},
        keywords = {Women’s health, nutraceuticals, phytoestrogens, isoflavones, omega-3 fatty acids, probiotics, vitamins, menopause, cardiometabolic health, cognitive f},
        month = {October},
        }